Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression
The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult neuroplasticity. The aim of the study was to examine in 77 patients with major depression and 77 healthy controls the association between the triallelic...
Gespeichert in:
Veröffentlicht in: | Molecular psychiatry 2008-12, Vol.13 (12), p.1093-1101 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1101 |
---|---|
container_issue | 12 |
container_start_page | 1093 |
container_title | Molecular psychiatry |
container_volume | 13 |
creator | Frodl, T Koutsouleris, N Bottlender, R Born, C Jäger, M Mörgenthaler, M Scheuerecker, J Zill, P Baghai, T Schüle, C Rupprecht, R Bondy, B Reiser, M Möller, H-J Meisenzahl, E M |
description | The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult neuroplasticity. The aim of the study was to examine in 77 patients with major depression and 77 healthy controls the association between the triallelic polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) and gray matter (GM) brain volumes measured with 1.5 T magnetic resonance imaging. Voxel-based morphometry were estimated on magnetic resonance images and genotyping was performed. We found that healthy controls have a strong association between the 5-HTTLPR and GM volumes of the dorsolateral prefrontal cortex, left anterior gyrus cinguli, left amygdala as well as right hippocampus, whereas there is no such association in patients with major depression. Healthy subjects carrying the S- or L
G
-allele have smaller GM volumes than those with the L
A
-allele, indicating that 5-HTTLPR contributes to the development of brain structures. Patients with depression show reduced GM volumes, particularly when they are homozygous for the L
A
-allele, suggesting that these patients are more vulnerable for morphological changes during depressive episodes. |
doi_str_mv | 10.1038/mp.2008.62 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_759318495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A190286149</galeid><sourcerecordid>A190286149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c559t-1a38d294f4955c64691332994735561abdebda2b920673fc4d2c63f2832479a73</originalsourceid><addsrcrecordid>eNqF0luL1DAUAOAiiruuvvgDJCgqKDM29-RxWbzBgiD6HDLp6WyGNqlJurL_3pQZdlB0pQ8pyXdOkpPTNE9xu8YtVe_GaU3aVq0FudecYibFinOp7td_yvWKYcVOmkc579p2WeQPmxOsq1eanzblK3Szgw5tk71Boy0FEtok6wO6jsM8QkY2AbI5R-dtqfCnL1fo2iZvQ8ko9qhcAcqQYomhRpVkQ55iWvJsIQCqc6PdxYQ6mBLk7GN43Dzo7ZDhyWE8a75_eP_t4tPq8svHzxfnlyvHuS4rbKnqiGY905w7wYTGlBKtmaScC2w3HWw6SzaatELS3rGOOEF7oihhUltJz5rX-7xTij9myMWMPjsYBhsgztlIrmmtjuZVvrpTCi0V14T-F2IttWRaVfjiD7iLcwr1uoYIxqVgsl1O-PyfimAsuGL8mGprBzA-9LEW2S37mvP6kkQJzHRV67-o-nUwehcD9L7O_xbwZh_gUsw5QW-m5EebbgxuzdJYZpzM0lhGkIqfHQ46b0bojvTQSRW8PACbnR362gbO51tHWsWW2lT3du9yXQpbSMcb37VtsGVOcJtunBZRwS9WFutg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221165845</pqid></control><display><type>article</type><title>Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Frodl, T ; Koutsouleris, N ; Bottlender, R ; Born, C ; Jäger, M ; Mörgenthaler, M ; Scheuerecker, J ; Zill, P ; Baghai, T ; Schüle, C ; Rupprecht, R ; Bondy, B ; Reiser, M ; Möller, H-J ; Meisenzahl, E M</creator><creatorcontrib>Frodl, T ; Koutsouleris, N ; Bottlender, R ; Born, C ; Jäger, M ; Mörgenthaler, M ; Scheuerecker, J ; Zill, P ; Baghai, T ; Schüle, C ; Rupprecht, R ; Bondy, B ; Reiser, M ; Möller, H-J ; Meisenzahl, E M</creatorcontrib><description>The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult neuroplasticity. The aim of the study was to examine in 77 patients with major depression and 77 healthy controls the association between the triallelic polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) and gray matter (GM) brain volumes measured with 1.5 T magnetic resonance imaging. Voxel-based morphometry were estimated on magnetic resonance images and genotyping was performed. We found that healthy controls have a strong association between the 5-HTTLPR and GM volumes of the dorsolateral prefrontal cortex, left anterior gyrus cinguli, left amygdala as well as right hippocampus, whereas there is no such association in patients with major depression. Healthy subjects carrying the S- or L
G
-allele have smaller GM volumes than those with the L
A
-allele, indicating that 5-HTTLPR contributes to the development of brain structures. Patients with depression show reduced GM volumes, particularly when they are homozygous for the L
A
-allele, suggesting that these patients are more vulnerable for morphological changes during depressive episodes.</description><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/mp.2008.62</identifier><identifier>PMID: 19008895</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adult ; Adult and adolescent clinical studies ; Alleles ; Amygdala ; Antidepressants ; Behavioral Sciences ; Biological and medical sciences ; Biological Psychology ; Brain ; Brain - pathology ; Brain Mapping ; Brain-derived neurotrophic factor ; Care and treatment ; Carrier proteins ; Central nervous system ; Depression ; Depressive Disorder, Major - genetics ; Depressive Disorder, Major - pathology ; Diagnosis ; DNA Mutational Analysis ; Dosage and administration ; Female ; Gene Frequency ; Gene polymorphism ; Genetic aspects ; Genetic Predisposition to Disease - genetics ; Genotype ; Genotyping ; Health aspects ; Humans ; Hypotheses ; Magnetic Resonance Imaging ; Major depressive disorder ; Male ; Medical imaging ; Medical sciences ; Medicine ; Medicine & Public Health ; Mental depression ; Mental disorders ; Middle Aged ; Mood disorders ; Morphology ; Morphometry ; Nervous system ; Neurogenesis ; Neuroimaging ; Neuroplasticity ; Neurosciences ; original-article ; Pathophysiology ; Pharmacotherapy ; Polymorphism ; Polymorphism, Genetic ; Prefrontal cortex ; Psychiatric Status Rating Scales ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychotherapy ; Serotonin ; Serotonin Plasma Membrane Transport Proteins - genetics ; Serotonin transporter ; Serotonin uptake inhibitors ; Substantia grisea</subject><ispartof>Molecular psychiatry, 2008-12, Vol.13 (12), p.1093-1101</ispartof><rights>Springer Nature Limited 2008</rights><rights>2009 INIST-CNRS</rights><rights>COPYRIGHT 2008 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Dec 2008</rights><rights>Nature Publishing Group 2008.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c559t-1a38d294f4955c64691332994735561abdebda2b920673fc4d2c63f2832479a73</citedby><cites>FETCH-LOGICAL-c559t-1a38d294f4955c64691332994735561abdebda2b920673fc4d2c63f2832479a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20841979$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19008895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frodl, T</creatorcontrib><creatorcontrib>Koutsouleris, N</creatorcontrib><creatorcontrib>Bottlender, R</creatorcontrib><creatorcontrib>Born, C</creatorcontrib><creatorcontrib>Jäger, M</creatorcontrib><creatorcontrib>Mörgenthaler, M</creatorcontrib><creatorcontrib>Scheuerecker, J</creatorcontrib><creatorcontrib>Zill, P</creatorcontrib><creatorcontrib>Baghai, T</creatorcontrib><creatorcontrib>Schüle, C</creatorcontrib><creatorcontrib>Rupprecht, R</creatorcontrib><creatorcontrib>Bondy, B</creatorcontrib><creatorcontrib>Reiser, M</creatorcontrib><creatorcontrib>Möller, H-J</creatorcontrib><creatorcontrib>Meisenzahl, E M</creatorcontrib><title>Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><description>The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult neuroplasticity. The aim of the study was to examine in 77 patients with major depression and 77 healthy controls the association between the triallelic polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) and gray matter (GM) brain volumes measured with 1.5 T magnetic resonance imaging. Voxel-based morphometry were estimated on magnetic resonance images and genotyping was performed. We found that healthy controls have a strong association between the 5-HTTLPR and GM volumes of the dorsolateral prefrontal cortex, left anterior gyrus cinguli, left amygdala as well as right hippocampus, whereas there is no such association in patients with major depression. Healthy subjects carrying the S- or L
G
-allele have smaller GM volumes than those with the L
A
-allele, indicating that 5-HTTLPR contributes to the development of brain structures. Patients with depression show reduced GM volumes, particularly when they are homozygous for the L
A
-allele, suggesting that these patients are more vulnerable for morphological changes during depressive episodes.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Alleles</subject><subject>Amygdala</subject><subject>Antidepressants</subject><subject>Behavioral Sciences</subject><subject>Biological and medical sciences</subject><subject>Biological Psychology</subject><subject>Brain</subject><subject>Brain - pathology</subject><subject>Brain Mapping</subject><subject>Brain-derived neurotrophic factor</subject><subject>Care and treatment</subject><subject>Carrier proteins</subject><subject>Central nervous system</subject><subject>Depression</subject><subject>Depressive Disorder, Major - genetics</subject><subject>Depressive Disorder, Major - pathology</subject><subject>Diagnosis</subject><subject>DNA Mutational Analysis</subject><subject>Dosage and administration</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Gene polymorphism</subject><subject>Genetic aspects</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genotype</subject><subject>Genotyping</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Magnetic Resonance Imaging</subject><subject>Major depressive disorder</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mental depression</subject><subject>Mental disorders</subject><subject>Middle Aged</subject><subject>Mood disorders</subject><subject>Morphology</subject><subject>Morphometry</subject><subject>Nervous system</subject><subject>Neurogenesis</subject><subject>Neuroimaging</subject><subject>Neuroplasticity</subject><subject>Neurosciences</subject><subject>original-article</subject><subject>Pathophysiology</subject><subject>Pharmacotherapy</subject><subject>Polymorphism</subject><subject>Polymorphism, Genetic</subject><subject>Prefrontal cortex</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychotherapy</subject><subject>Serotonin</subject><subject>Serotonin Plasma Membrane Transport Proteins - genetics</subject><subject>Serotonin transporter</subject><subject>Serotonin uptake inhibitors</subject><subject>Substantia grisea</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0luL1DAUAOAiiruuvvgDJCgqKDM29-RxWbzBgiD6HDLp6WyGNqlJurL_3pQZdlB0pQ8pyXdOkpPTNE9xu8YtVe_GaU3aVq0FudecYibFinOp7td_yvWKYcVOmkc579p2WeQPmxOsq1eanzblK3Szgw5tk71Boy0FEtok6wO6jsM8QkY2AbI5R-dtqfCnL1fo2iZvQ8ko9qhcAcqQYomhRpVkQ55iWvJsIQCqc6PdxYQ6mBLk7GN43Dzo7ZDhyWE8a75_eP_t4tPq8svHzxfnlyvHuS4rbKnqiGY905w7wYTGlBKtmaScC2w3HWw6SzaatELS3rGOOEF7oihhUltJz5rX-7xTij9myMWMPjsYBhsgztlIrmmtjuZVvrpTCi0V14T-F2IttWRaVfjiD7iLcwr1uoYIxqVgsl1O-PyfimAsuGL8mGprBzA-9LEW2S37mvP6kkQJzHRV67-o-nUwehcD9L7O_xbwZh_gUsw5QW-m5EebbgxuzdJYZpzM0lhGkIqfHQ46b0bojvTQSRW8PACbnR362gbO51tHWsWW2lT3du9yXQpbSMcb37VtsGVOcJtunBZRwS9WFutg</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>Frodl, T</creator><creator>Koutsouleris, N</creator><creator>Bottlender, R</creator><creator>Born, C</creator><creator>Jäger, M</creator><creator>Mörgenthaler, M</creator><creator>Scheuerecker, J</creator><creator>Zill, P</creator><creator>Baghai, T</creator><creator>Schüle, C</creator><creator>Rupprecht, R</creator><creator>Bondy, B</creator><creator>Reiser, M</creator><creator>Möller, H-J</creator><creator>Meisenzahl, E M</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20081201</creationdate><title>Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression</title><author>Frodl, T ; Koutsouleris, N ; Bottlender, R ; Born, C ; Jäger, M ; Mörgenthaler, M ; Scheuerecker, J ; Zill, P ; Baghai, T ; Schüle, C ; Rupprecht, R ; Bondy, B ; Reiser, M ; Möller, H-J ; Meisenzahl, E M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c559t-1a38d294f4955c64691332994735561abdebda2b920673fc4d2c63f2832479a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Alleles</topic><topic>Amygdala</topic><topic>Antidepressants</topic><topic>Behavioral Sciences</topic><topic>Biological and medical sciences</topic><topic>Biological Psychology</topic><topic>Brain</topic><topic>Brain - pathology</topic><topic>Brain Mapping</topic><topic>Brain-derived neurotrophic factor</topic><topic>Care and treatment</topic><topic>Carrier proteins</topic><topic>Central nervous system</topic><topic>Depression</topic><topic>Depressive Disorder, Major - genetics</topic><topic>Depressive Disorder, Major - pathology</topic><topic>Diagnosis</topic><topic>DNA Mutational Analysis</topic><topic>Dosage and administration</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Gene polymorphism</topic><topic>Genetic aspects</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genotype</topic><topic>Genotyping</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Magnetic Resonance Imaging</topic><topic>Major depressive disorder</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mental depression</topic><topic>Mental disorders</topic><topic>Middle Aged</topic><topic>Mood disorders</topic><topic>Morphology</topic><topic>Morphometry</topic><topic>Nervous system</topic><topic>Neurogenesis</topic><topic>Neuroimaging</topic><topic>Neuroplasticity</topic><topic>Neurosciences</topic><topic>original-article</topic><topic>Pathophysiology</topic><topic>Pharmacotherapy</topic><topic>Polymorphism</topic><topic>Polymorphism, Genetic</topic><topic>Prefrontal cortex</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychotherapy</topic><topic>Serotonin</topic><topic>Serotonin Plasma Membrane Transport Proteins - genetics</topic><topic>Serotonin transporter</topic><topic>Serotonin uptake inhibitors</topic><topic>Substantia grisea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frodl, T</creatorcontrib><creatorcontrib>Koutsouleris, N</creatorcontrib><creatorcontrib>Bottlender, R</creatorcontrib><creatorcontrib>Born, C</creatorcontrib><creatorcontrib>Jäger, M</creatorcontrib><creatorcontrib>Mörgenthaler, M</creatorcontrib><creatorcontrib>Scheuerecker, J</creatorcontrib><creatorcontrib>Zill, P</creatorcontrib><creatorcontrib>Baghai, T</creatorcontrib><creatorcontrib>Schüle, C</creatorcontrib><creatorcontrib>Rupprecht, R</creatorcontrib><creatorcontrib>Bondy, B</creatorcontrib><creatorcontrib>Reiser, M</creatorcontrib><creatorcontrib>Möller, H-J</creatorcontrib><creatorcontrib>Meisenzahl, E M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frodl, T</au><au>Koutsouleris, N</au><au>Bottlender, R</au><au>Born, C</au><au>Jäger, M</au><au>Mörgenthaler, M</au><au>Scheuerecker, J</au><au>Zill, P</au><au>Baghai, T</au><au>Schüle, C</au><au>Rupprecht, R</au><au>Bondy, B</au><au>Reiser, M</au><au>Möller, H-J</au><au>Meisenzahl, E M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>13</volume><issue>12</issue><spage>1093</spage><epage>1101</epage><pages>1093-1101</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><abstract>The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult neuroplasticity. The aim of the study was to examine in 77 patients with major depression and 77 healthy controls the association between the triallelic polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) and gray matter (GM) brain volumes measured with 1.5 T magnetic resonance imaging. Voxel-based morphometry were estimated on magnetic resonance images and genotyping was performed. We found that healthy controls have a strong association between the 5-HTTLPR and GM volumes of the dorsolateral prefrontal cortex, left anterior gyrus cinguli, left amygdala as well as right hippocampus, whereas there is no such association in patients with major depression. Healthy subjects carrying the S- or L
G
-allele have smaller GM volumes than those with the L
A
-allele, indicating that 5-HTTLPR contributes to the development of brain structures. Patients with depression show reduced GM volumes, particularly when they are homozygous for the L
A
-allele, suggesting that these patients are more vulnerable for morphological changes during depressive episodes.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>19008895</pmid><doi>10.1038/mp.2008.62</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1359-4184 |
ispartof | Molecular psychiatry, 2008-12, Vol.13 (12), p.1093-1101 |
issn | 1359-4184 1476-5578 |
language | eng |
recordid | cdi_proquest_miscellaneous_759318495 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Adult and adolescent clinical studies Alleles Amygdala Antidepressants Behavioral Sciences Biological and medical sciences Biological Psychology Brain Brain - pathology Brain Mapping Brain-derived neurotrophic factor Care and treatment Carrier proteins Central nervous system Depression Depressive Disorder, Major - genetics Depressive Disorder, Major - pathology Diagnosis DNA Mutational Analysis Dosage and administration Female Gene Frequency Gene polymorphism Genetic aspects Genetic Predisposition to Disease - genetics Genotype Genotyping Health aspects Humans Hypotheses Magnetic Resonance Imaging Major depressive disorder Male Medical imaging Medical sciences Medicine Medicine & Public Health Mental depression Mental disorders Middle Aged Mood disorders Morphology Morphometry Nervous system Neurogenesis Neuroimaging Neuroplasticity Neurosciences original-article Pathophysiology Pharmacotherapy Polymorphism Polymorphism, Genetic Prefrontal cortex Psychiatric Status Rating Scales Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychotherapy Serotonin Serotonin Plasma Membrane Transport Proteins - genetics Serotonin transporter Serotonin uptake inhibitors Substantia grisea |
title | Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A26%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20gray%20matter%20brain%20volumes%20are%20associated%20with%20variants%20of%20the%20serotonin%20transporter%20gene%20in%20major%20depression&rft.jtitle=Molecular%20psychiatry&rft.au=Frodl,%20T&rft.date=2008-12-01&rft.volume=13&rft.issue=12&rft.spage=1093&rft.epage=1101&rft.pages=1093-1101&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/mp.2008.62&rft_dat=%3Cgale_proqu%3EA190286149%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221165845&rft_id=info:pmid/19008895&rft_galeid=A190286149&rfr_iscdi=true |